Selected Tag:
Eris Lifesciences
Selected Tag:
Eris Lifesciences
Eris Lifesciences to buy remaining 30% in Swiss Parenterals for ₹4.23 billion
BasisPoint Insight
November 25, 2025 at 10:20 AM IST
Eris Lifesciences Reappoints MD And Wholetime Directors For New Five-Year Terms
BasisPoint Insight
July 1, 2025 at 9:31 AM IST
The Bureau
Bears Dominate Dalal Street, Equities Log Decline Led by Financials
Pakistan Bombs Afghan Cities, Minister Says it is ‘Open War’: Reports
Risk Appetite Wavers After Nvidia Slide and Iran Talks Stall
SEBI Overhauls Mutual Fund Categories, Ends Solution-Oriented Plans
Stablecoins Are Raising New Risks for Emerging Markets
FTA Revival and Uranium Deal Could Define Carney’s Visit: GTRI
US Slaps 126% Duty on Indian Solar Exports, Subsidised Parts From China Under Lens
See All
Duvvuri Subbarao on India’s Growth, Inflation Targeting and Centre–State Faultlines
Learning to Shoot: I Tried to Fly Before I Could Walk